Anybody see it way, way different?
If your thesis is right, that folks are playing out some lesson they learned from the past, then maybe it's just as likely their selling now will become the basis for some future lesson, the "let it ride" lesson.
There was a rumor today about Roche buying Geron, I went over to the Yahoo GERN board to get a sentiment check, about three to one skeptics and GERN bashers over those thinking the fit made sense. I don't know, it just seems like a lot of skepticism, not only about GERN and biotechs, but everything-equity. Doesn't "feel" like a top to me, not a significant one anyway. |
